JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB9255

Anti-RFX5 抗体

Anti-RFX5 antibody

5

(1 Review)

|

(4 Publications)

Rabbit Polyclonal RFX5 antibody. Suitable for WB and reacts with Human samples. Cited in 4 publications. Immunogen corresponding to Synthetic Peptide within Human DNA-binding protein RFX5 conjugated to Keyhole Limpet Haemocyanin.

別名を表示する

DNA-binding protein RFX5, Regulatory factor X 5, RFX5

1 Images
Western blot - Anti-RFX5 antibody (AB9255)
  • WB

Unknown

Western blot - Anti-RFX5 antibody (AB9255)

ab9255 at a 1 : 1000 dilution staining RFX5 in 500μg of HeLa Nuclear Extract by Western Blot (ECL). Immunoprecipitation was performed prior to Western Blotting with 2.0μg of ab9255. ab9255 at a 1 : 1000 dilution staining RFX5 in 500µg of HeLa Nuclear Extract by Western Blot (ECL). Immunoprecipitation was performed prior to Western Blotting with 2.0µg of ab9255.

All lanes:

Western blot - Anti-RFX5 antibody (ab9255)

Predicted band size: 65 kDa

false

Key facts

宿主種

Rabbit

クローン性

Polyclonal

アイソタイプ

IgG

キャリアフリー

No

交差種

Human

アプリケーション

WB

applications

免疫原

Synthetic Peptide within Human DNA-binding protein RFX5 conjugated to Keyhole Limpet Haemocyanin. The exact immunogen used to generate this antibody is proprietary information.

P48382

style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/5000", "WB-species-notes": "<p></p>" }, "Chimpanzee": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Gorilla": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" } } }
style
left-column
style
left-column

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Immunogen
精製に関する特記事項
Antibodies were affinity purified using thepeptide immobilized on solid support. Antibody concentration was determined by extinction coefficient: absorbance at 280 nmof 1.4 equals 1.0 mg of IgG.
バッファー組成
pH: 7 - 8 Preservative: 0.1% Sodium azide Constituents: PBS, 1.815% Tris, 1.764% Sodium citrate
出荷温度
Blue Ice
短期保存温度
+4°C
長期保存温度
+4°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle
style
left-column

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

RFX5 also known as Regulatory Factor X 5 is a transcription factor characterized by a mass of approximately 74 kDa. It plays an essential role in the modulation and transcriptional regulation of genes. RFX5 is predominantly expressed in the nucleus of human cells where it binds to DNA and regulates gene expression. This protein is vital to the regulation of major histocompatibility complex (MHC) class II genes affecting how cells present antigens.
Biological function summary

RFX5 functions as part of the RFX complex an important element for the transcription of MHC class II genes. It interacts with other regulatory factor X proteins to form this complex enabling the activation of target gene transcription. RFX5 acts by binding to the X box motifs within the promoters of the MHC class II genes. Its presence is necessary to maintain the immune response capability by ensuring the expression of these genes which is a fundamental process in antigen presentation to immune cells.

Pathways

RFX5 integrates into the MHC class II antigen presentation pathway. It has a significant relationship with the CIITA transcriptional regulator with CIITA enhancing the activity of RFX5 during the assembly of the MHC class II transcriptional machinery. Another important pathway is the immune response pathway where RFX5 is important in coordinating the expression of genes that help the immune system recognize and respond to pathogens effectively.

Deficiencies or malfunctions in RFX5 have strong connections with Bare Lymphocyte Syndrome (BLS) type II marked by reduced expression of MHC class II molecules. In this context RFX5's interactions with CIITA are critical because improper function of either can lead to compromised immune responses. Studies also suggest an association between disrupted RFX5 activity and autoimmune diseases where improper antigen presentation can lead to the immune system attacking the body's own tissues.
style
left-column
style
left-column

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

ターゲットの情報

Activates transcription from class II MHC promoters. Recognizes X-boxes. Mediates cooperative binding between RFX and NF-Y. RFX binds the X1 box of MHC-II promoters.
See full target information DNA-binding protein RFX5
style
left-column

文献 (4)

Recent publications for all applications. Explore the full list and refine your search

Cell death & disease 12:349 PubMed33824282

2021

ZEB1-induced LINC01559 expedites cell proliferation, migration and EMT process in gastric cancer through recruiting IGF2BP2 to stabilize ZEB1 expression.

Applications

Unspecified application

Species

Unspecified reactive species

Huojian Shen,Hongyi Zhu,Yuanwen Chen,Zhiyong Shen,Weiqing Qiu,Changlin Qian,Jie Zhang

Circulation 138:1850-1863 PubMed29794082

2018

Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages.

Applications

Unspecified application

Species

Unspecified reactive species

Paul A Mueller,Lin Zhu,Hagai Tavori,Katherine Huynh,Ilaria Giunzioni,John M Stafford,MacRae F Linton,Sergio Fazio

Oncotarget 8:93878-93898 PubMed29212196

2017

Juglanin inhibits lung cancer by regulation of apoptosis, ROS and autophagy induction.

Applications

Unspecified application

Species

Unspecified reactive species

Liang Chen,Ya-Qiong Xiong,Jing Xu,Ji-Peng Wang,Zi-Li Meng,Yong-Qing Hong

Molecular microbiology 61:1543-55 PubMed16968227

2006

Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle.

Applications

Unspecified application

Species

Unspecified reactive species

K Wolf,H J Betts,B Chellas-Géry,S Hower,C N Linton,K A Fields
View all publications
style
left-column
style
left-column
style
right-column

組合せ製品

Primary Antibodies

AB179805

Anti-GANAB antibody [EPR12377(B)]

RabMAb|Recombinant|KO Validated

Flow Cytometry (Intracellular) - Anti-GANAB antibody [EPR12377(B)] (AB179805)

  • 0
  • 0
Primary Antibodies

AB106568

Anti-SLC39A14/ZIP-14 antibody

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SLC39A14/ZIP-14 antibody (AB106568)

  • 0
  • 0
Primary Antibodies

AB228576

Anti-POLRMT antibody

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-POLRMT antibody (AB228576)

  • 0
  • 0
Primary Antibodies

AB203346

Anti-Melatonin Receptor 1B/MTNR1B antibody

Immunocytochemistry/ Immunofluorescence - Anti-Melatonin Receptor 1B/MTNR1B antibody (AB203346)

  • 0
  • 0

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com